You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Claims for Patent: 7,698,069


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,698,069
Title:Method for designing primer for realtime PCR
Abstract: A method for designing a primer for real-time PCR comprises retrieving a primer set using a known primer search algorithm and based on primer design conditions, visually displaying the retrieved primer set together with its splicing information and base sequence, narrowing the primer set using narrowing conditions, and visually displaying a narrowed primer set together with its splicing information and base sequence.
Inventor(s): Yamamoto; Takamune (Tokyo, JP)
Assignee: Hitachi Software Engineering Co., Ltd. (Kanagawa, JP)
Application Number:11/185,892
Patent Claims:1. A method for designing a primer for real-time PCR and implemented on a computer suitably configured and programmed to implement said method, comprising: a file selection step for entering a base sequence data file regarding a target gene; a determining step for determining whether or not said base sequence data file contains splicing information; a splicing information calculation step for calculating splicing information if it is determined in said determination step that splicing information is not contained; a parameter input step for inviting and receiving entries of primer design conditions by displaying splicing information which includes a length of an intron sequence removed by splicing and a position of binding by splicing in a schematic fashion; a first primer design step for designing primer sets using a known primer search algorithm and in accordance with said primer design conditions and displaying a screen for inviting and receiving entries of conditions for narrowing designed results; a narrowing step for narrowing the designed results in accordance with said conditions for narrowing designed results if an indication for narrowing designed results is entered into the computer; a detailed information display step for displaying a detailed information screen which includes a field for displaying said splicing information which includes the length of intron sequence removed by splicing and the position of binding by splicing in a schematic fashion, a field for displaying position information regarding a plurality of primer sets which include a plurality of primers on the nonsense strand side each relative to one primer on sense strand side, and a field for displaying detailed information of primer sets as selected in said field for displaying the position information regarding a plurality of primer sets; a second primer designing step for designing a primer for preparing an analytical curve-creating template if an indication for designing primer sets for preparing an analytical curve-creating template is entered in the computer; and a primer information output step for output information of the primer sets as designed to a file.

2. The method for designing a primer for real-time PCR according to claim 1, wherein said primer design conditions include the exon numbers on the left and right sides of intron, or the intron number between exons.

3. The computer implemented method for designing a primer for real-time PCR according to claim 1, wherein the second primer set designing step designs the primer set for preparing a template for creating an analytical curve by performing a known primer search algorithm while excluding an area sandwiched between the selected primer set in said field for displaying detailed information of primer sets in said detailed information screen.

4. The computer implemented method for designing a primer for real-time PCR according to claim 1, wherein the splicing information calculation step involves: entering a genomic DNA base sequence, while the base sequence being an mRNA base sequence; processing the base sequence as a character string, substituting an initial value of zero in a variable "DNA position" and a variable "mRNA position," and entering an initial value of zero in a variable "exon number" which counts the number of exons; substituting ten characters from the "mRNA position" in the mRNA base sequence in a character string "Searched sequence"; retrieving sequences corresponding to the genomic DNA base sequence from the "DNA position," and obtaining all mRNA base sequences included in the genomic DNA base sequence by splicing; determining whether there is one of the mRNA base sequences corresponding to the base sequence: if no, terminating the splicing information calculation step; if yes, using a subscript of a corresponding letter in the genomic DNA base sequence as a corresponding position, substituting a corresponding letter into a variable "exon start position" and the "DNA position," and incrementing the "exon number", the "mRNA position" and the "DNA position"; comparing letter by letter starting from a letter following the "DNA position" in the genomic DNA base sequence with a letter in the "mRNA position" in the mRNA base sequence, if the letters correspond with each other, incrementing the "mRNA position" and the "DNA positiont"; substituting the "DNA position" into a variable "exon end position," and adding the "exon number," the "exon start position," and the "exon end position" into the splicing information; and determining whether the "mRNA position" is at the end of the mRNA base sequence: if not, returning to the step of substituting ten characters, if yes, outputting the splicing information.

Details for Patent 7,698,069

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 06/04/1986 ⤷  Try a Trial 2024-09-01
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 ⤷  Try a Trial 2024-09-01
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b Injection 103132 ⤷  Try a Trial 2024-09-01
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.